Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective

Regarder maintenant Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective

A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)

Regarder maintenant A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)

Expected medium- and long-term impact of the COVID-19 on Breast Cancer Treatment in Quebec

Regarder maintenant Expected medium- and long-term impact of the COVID-19 on Breast Cancer Treatment in Quebec

SABCS 2020 - Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis

Regarder maintenant SABCS 2020 - Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis

SABCS 2020 - First results from a phase III randomized clinical trial SWOG S1007 (RxPonder)

Regarder maintenant SABCS 2020 - First results from a phase III randomized clinical trial SWOG S1007 (RxPonder)